Detailed answers about AMO-01 PHARMA LIMITED, including incorporation, status, business activity, and accounts information.
When was AMO-01 PHARMA LIMITED founded?
AMO-01 PHARMA LIMITED was officially incorporated on 9 July 2021 and is registered under company number 13502777. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is AMO-01 PHARMA LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of AMO-01 PHARMA LIMITED?
AMO-01 PHARMA LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does AMO-01 PHARMA LIMITED do?
AMO-01 PHARMA LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is AMO-01 PHARMA LIMITED's registered address?
The registered office address of AMO-01 PHARMA LIMITED is BURNHAM HOUSE, SPLASH LANE, WYTON, HUNTINGDON, ENGLAND, PE28 2AF. This is the official address filed with Companies House for legal and statutory correspondence.
Is AMO-01 PHARMA LIMITED financially stable?
The most recent accounts for AMO-01 PHARMA LIMITED were made up to 31 December 2024, filed as DORMANT. Next accounts are due by 30 September 2026.
Does AMO-01 PHARMA LIMITED have any charges or mortgages?
AMO-01 PHARMA LIMITED has 2 registered charges, of which 2 are outstanding, 0 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.